ALIAXIN - IBSA DERMA

Fundado por un grupo de biólogos suizos en 1945, IBSA (Institut Biochimie SA) ha adquirido una experiencia única en investigación y tecnología farmacéutica. Al centrarse en el desarrollo de innovaciones que optimizan las moléculas existentes y las soluciones terapéuticas, la empresa ha experimentado un rápido crecimiento y también se ha expandido internacionalmente; hoy, sus productos están disponibles en más de 80 países, en los 5 continentes. Gracias a su experiencia científica, investigación continua, desarrollo tecnológico y un moderno proceso de producción, IBSA Derma se ha convertido en una de las compañías farmacéuticas líderes en la producción de ácido hialurónico para aplicaciones dermoestéticas.

PRODUCT RANGE

The ALIAXIN range takes full advantage of HA characteristics, supporting not only the LIFT action (filling) but also the HYDRO action through rehydration and tissue stimulation.

MODELAGE

• ALIAXIN SR SHAPE & RESTORE
• ALIAXIN FL LIPS
• ALIAXIN GP GLOBAL PERFORMANCE

VOLUMISATION

• ALIAXIN LV LIPS VOLUME
• ALIAXIN EV ESSENTIAL VOLUME
• ALIAXIN SV SUPERIOR VOLUME

Formulations of the ALIAXIN product line with specific and different visco-elastic properties are the result of IBSA research. IBSA technology is able to guarantee different clinical results using a combination of hyaluronic acid with different molecular weights while acting on the cross-linking grade.

PRODUCT SUMMARY

Aliaxin Dermal Filler. ALIAXIN is a monophasic dermal filler product range containing a combination of well-defined molecular weights of hyaluronic acid to obtain different biological and mechanical effects. Key features of the ALIAXIN are high tissue integration and stability, resulting in natural, but at the same time long-lasting results. It is manufactured by IBSA Farmaceutici Italia in a U.S. FDA approved site in Italy, and distributed in the UK & Ireland by HA-Derma Ltd.

GENERIC NAME

Non-animal hyaluronic acid (HA).

WHAT DOES IT CONTAIN?

IBSA’s hyaluronic acid is an ultrapure grade hyaluronic acid, produced through a patented bio-fermentation process, of Streptococcus Zooepidemicus, which ranks worldwide as ‘top quality’ in terms of purity, safety and its high resistance to thermal production processes.

HOW IS IT MADE?

The ALIAXIN cross-linking process results in a ready-to-use gel without the need for additional fragmentation or manipulation, with a low cross-linking percentage (<10%) and a low content of BDDE residue (<0.1ppm). All of which makes the final product safer and easier to inject thanks to the optimisation of the viscoelastic characteristics.

IS A SKIN TEST REQUIRED BEFORE TREATMENT?

No allergy test needed.

IS IT TEMPORARY OR PERMANENT?

Hyaluronic acid is completely broken down within the skin over a period of months, eventually leaving no trace of the filler.

LICENCED STATUS

Medical device. CE  Marked.

SHOULD BE USED BY

Trained members of the medical profession only.